Arnicare Leg Cramps Tablet
NDC Package 0220-9079-04
Package Information
Arnicare Leg Cramps (arnica montana whole, copper, magnesium phosphate, dibasic trihydrate, strychnos nux-vomica seed, passiflora incarnata top, claviceps purpurea sclerotium) tablets is uses* temporarily relieves nighttime cramps in legs, thighs, calves, feet, and toes with accompanying occasional disrupted sleep. This formulation utilizes a tablet delivery system. Marketed by Laboratoires Boiron, this product is identified by NDC 0220-9079.
Identification & Billing
Clinical Specifications
- Allergens - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Copper - [CS]
- Copper-containing Intrauterine Device - [EPC] (Established Pharmacologic Class)
- Decreased Embryonic Implantation - [PE] (Physiologic Effect)
- Decreased Sperm Motility - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibit Ovum Fertilization - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 0220 - Laboratoires Boiron
- 0220-9079 - Arnicare Leg Cramps
- 0220-9079-04 - 1 BLISTER PACK in 1 CARTON / 60 TABLET in 1 BLISTER PACK
- 0220-9079 - Arnicare Leg Cramps
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0220-9079). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0220-9079-04 identifies a specific commercial package of 1 blister pack in 1 carton / 60 tablet in 1 blister pack of Arnicare Leg Cramps, a human over the counter drug labeled by Laboratoires Boiron. This tablet is formulated for oral use and contains arnica montana; claviceps purpurea sclerotium; copper; magnesium phosphate, dibasic trihydrate; passiflora incarnata top; strychnos nux-vomica seed as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Laboratoires Boiron on September 11, 2023. The current certification is valid through December 31, 2026.
How is this Laboratoires Boiron product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00220907904. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.